Literature DB >> 9510473

Frameshift mutations of the hMSH6 gene in human leukemia cell lines.

N Hosoya1, A Hangaishi, S Ogawa, K Miyagawa, K Mitani, Y Yazaki, H Hirai.   

Abstract

Defects in DNA mismatch repair mechanisms, including frameshift mutations of the hMSH6 and hMSH3 genes at their (C)8 and (A)8 tracks, respectively, have been shown to be associated with human malignancies. To clarify the possible involvement of these mutations in hematopoietic malignancies, we screened a total of forty-four human leukemia and lymphoma cell lines for mutations in the hMSH6 and hMSH3 genes, as well as in other genes required for DNA replication or repair, by polymerase chain reaction single-strand conformation polymorphism analysis and sequencing analysis. Frameshift mutations at the (C)8 track of the hMSH6 gene were detected in two cell lines established from lymphoid leukemias. These two cell lines had no wild-type alleles, and both of them showed microsatellite instability. This is the first report that describes mutations and inactivation of the hMSH6 gene in hematological malignancies, suggesting that defects of the hMSH6 gene may be associated with development of hematological malignancies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510473      PMCID: PMC5921588          DOI: 10.1111/j.1349-7006.1998.tb00476.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Frameshift mutator mutations.

Authors:  S Malkhosyan; N Rampino; H Yamamoto; M Perucho
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

2.  Polymerase delta variants in RER colorectal tumours.

Authors:  L T da Costa; B Liu; W el-Deiry; S R Hamilton; K W Kinzler; B Vogelstein; S Markowitz; J K Willson; A de la Chapelle; K M Downey
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

3.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

4.  Genetic instability of microsatellites in hematological neoplasms.

Authors:  M Robledo; B Martinez; E Arranz; M J Trujillo; A Gonzalez Ageitos; C Rivas; J Benitez
Journal:  Leukemia       Date:  1995-06       Impact factor: 11.528

5.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Genetic instability occurs in the majority of young patients with colorectal cancer.

Authors:  B Liu; S M Farrington; G M Petersen; S R Hamilton; R Parsons; N Papadopoulos; T Fujiwara; J Jen; K W Kinzler; A H Wyllie; B Vogelstein; M G Dunlop
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

7.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

8.  Mutations of GTBP in genetically unstable cells.

Authors:  N Papadopoulos; N C Nicolaides; B Liu; R Parsons; C Lengauer; F Palombo; A D'Arrigo; S Markowitz; J K Willson; K W Kinzler
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

9.  Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.

Authors:  L A Aaltonen; P Peltomäki; J P Mecklin; H Järvinen; J R Jass; J S Green; H T Lynch; P Watson; G Tallqvist; M Juhola
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Mutational analysis of mismatch repair genes, hMLH1 and hMSH2, in sporadic endometrial carcinomas with microsatellite instability.

Authors:  K Kobayashi; M Matsushima; S Koi; H Saito; S Sagae; R Kudo; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  1996-02
View more
  1 in total

1.  Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.

Authors:  Terzah M Horton; Gaye Jenkins; Debananda Pati; Linna Zhang; M Eileen Dolan; Albert Ribes-Zamora; Alison A Bertuch; Susan M Blaney; Shannon L Delaney; Madhuri Hegde; Stacey L Berg
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.